Blueprint Medicines

Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets

Founded:
2011
Founders:
Brian Druker, Alexis Borisy
Employees:
51 - 100
  • LinkedIn

Popular Blueprint Medicines's Searches

Lusha complements profiles with B2B contact and company information for FREE

Find contact information about Blueprint Medicines and other companies

FIND THEM. IT'S FREE!

Sign Up Now. It's Fast & Easy.

Blueprint Medicines's Employee Email Address Formats

Blueprint Medicines uses 3 email formats, with first_initial last (ex. jsmith@blueprintmedicines.com)
being used 91% of the time.
first_initial lastjsmith@blueprintmedicines.com91%
first last_initialjohns@blueprintmedicines.com2%
other_templateother_template@blueprintmedicines.com6%